Anup Agarwal

Anup Agarwal practices at CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance.

Anup Agarwal's NPI, 1366844722, was assigned on September 17, 2014. Anup Agarwal holds Maryland license D0091836.

Anup Agarwal's primary practice is CHA Cambridge Hospital, at 1493 Cambridge Street, Cambridge, MA 02139 in Middlesex County. The practice phone is (617) 665-1000.

Anup Agarwal's primary practice is CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance. The medical group on file is Cambridge Health Alliance. Anup Agarwal's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Anup Agarwal practices. Vendor and product names are available with a free account.

Internal medicine is Anup Agarwal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Anup Agarwal is licensed in Maryland.

CMS data shows 413 Medicare services from Anup Agarwal across 4 procedure codes in 2024, for 138 Medicare patients. Medicare paid $43,673 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 138 Medicare patients who saw Anup Agarwal in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anup Agarwal's median patient age at 63, with 42% women.

In 2024, Anup Agarwal wrote 62 Medicare Part D claims for 21 patients. 81% of them were for generic drugs.

Anup Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1 general payment to Anup Agarwal from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Stemline Therapeutics Inc. paid the most, $34.